Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis. [electronic resource]
Producer: 20140210Description: 3766-74 p. digitalISSN:- 1460-2156
- Acetazolamide -- pharmacology
- Animals
- Arginine -- genetics
- Bumetanide -- therapeutic use
- Calcium Channels, L-Type -- genetics
- Carbonic Anhydrase Inhibitors -- pharmacology
- Disease Models, Animal
- Evoked Potentials, Motor -- drug effects
- Furosemide -- pharmacology
- Glucose -- metabolism
- Histidine -- genetics
- Hypokalemic Periodic Paralysis -- drug therapy
- In Vitro Techniques
- Isometric Contraction -- drug effects
- Male
- Mice
- Mice, Transgenic
- Muscle, Skeletal -- physiopathology
- Mutation -- genetics
- Sodium Potassium Chloride Symporter Inhibitors -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.